Anti-adult T‑cell leukemia/lymphoma activity of cerdulatinib, a dual SYK/JAK kinase inhibitor

Chie Ishikawa(University of the Ryukyus), Naoki Mori(Fukuoka City Hospital)
International Journal of Oncology
August 1, 2018
Cited by 25


Related Papers